Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
Research Tree provides access to ongoing research coverage, media content and regulatory news on Sphere 3D Corp. We currently have 0 research reports from 0 professional analysts.
Companies: Cerillion Plc
Liberum
Companies: TruFin Plc
itim is a disruptive SaaS and services platform that enables store-based retailers to implement a proven Omni-channel solution. This morning, the group has reported full year results to 31 December 2023, in line with February's trading update and with significant progress in product development and notable contract wins post-year end. Revenue in the year increased 15%, primarily driven by a 54% increase in service revenue, as itim looked to shift its focus from subscription growth to paid-for se
Companies: Itim Group PLC
WHIreland
We initiate coverage of NCC Group, a well-respected provider of cyber security and software escrow solutions. In FY23, the company experienced a significant market pullback that revealed operational deficiencies. The company appointed a new CEO, who introduced a turnaround strategy in January 2023. We believe the ongoing improvements are transformational and consensus expectations underestimate NCC’s revenue growth and margin potential. In addition, shares trade below historic multiples and thos
Companies: NCC Group plc
Zeus Capital
Intelligent Ultrasound has reported its results for the 12 months to December 2023. In line with the January trading update, the company has reported group revenues of £11.2m, up 11% reported or c36% adjusting for one-off sales in FY22. Importantly, the company generated £2.0m from its Clinical AI product portfolio versus £0.7m in FY22 and we note GE HealthCare has expanded the range of Voluson ultrasound machines that include SonoLyst, powered by Intelligent Ultrasound’s ScanNav software. The c
Companies: Intelligent Ultrasound Group Plc
Cavendish
Made Tech is a leading provider of digital, data, and technology services to the UK public sector. The Group was founded in 2008 by Rory MacDonald (CEO), who remains its main shareholder with 28% of the equity, and IPO’d in 2021. The Group is entirely exposed to the UK public sector and we believe this represents a large structural growth opportunity as the shift to digital services is likely to accelerate. Moreover, we believe Made Tech will continue to benefit from the transition away from UK
Companies: Made Tech Group PLC
H2 Radnor
Companies: 88E MTC TIA DEC ULTP
Organic growth and margin expansion in Q1 24 WIIT posted a 5.4% sales growth to EUR33.5m, roughly in line with our expectations and almost entirely driven by organic growth. The company adjusted EBITDA was EUR13m (vs. EUR12.5m expected) with a margin of 38.8% (vs. 37%e) thanks to better sales mix, lower services costs, and lower provisions. The company adjusted EBIT was EUR7.2m and the company adjusted Net Profit at EUR4.1m. Net debt reached EUR203.1m (EUR202m in FY23) after c.EUR9.6m of capex.
Companies: WIIT SpA
BNP Paribas Exane - Sponsored Research
MoneyHero is a leading South-East Asian personal finance aggregator and comparison platform, covering the full suite of personal finance products. Its goal is to educate and empower consumers on personal finance through engaging content and rewards on financial products. The company partners with leading local and global financial institutions to ensure it has the most attractive products and offers for its user base. Management has ambitious plans to grow market share and attractive product ver
Companies: MoneyHero Limited
Edison
Proving that market anxiety over the 1H/2H split is misplaced, Celebrus management is demonstrating confidence in the visibility in the model with confirmation of revenue performance in line with expectations and adjusted PBT 5% ahead (and by consequence adj dil EPS +5%) close to two weeks before the March year end. £32.0m revenue (consensus £32.1m; Cav £32.3m). £32m achieves the punchy 50% target organic growth after some hardware focused contracts held over into FY24; while £5.5m adj PBT (cons
Companies: Celebrus Technologies PLC
In FY23 results to December, UK-based managed services provider Tialis Essential IT has reported +55% revenue growth in-line at £22.4m (was £22.0mE), profitability at the adj PBT level of £1.1m (FY22: £-0.6m) despite higher-than-expected exceptional costs and £3.7m net debt, demonstrating the benefits of previous restructuring across the Group. The successful acquisition and integration of lower-margin, revenue-accretive Allvotec contracts led to lower than expected 30% gross margin, which we ex
Companies: Tialis Essential IT PLC
Light Science Technologies Holdings has conditionally raised £1.5m (gross) through a placing and private subscription at 1p/share. The company also intends to raise up to £0.5m (gross) at 1p/share via the Winterflood Retail Access platform. The proceeds will predominantly be used for product development and intellectual property protection in the company’s controlled environment agriculture (CEA) division, as well as for general working capital purposes.
Companies: Light Science Technologies Holdings plc
The Hardman & Co Healthcare Index (HHI) has been running since 2009. Its main function is to highlight the attractions of life sciences investments over the long term. For the second year running, apart from global economic influences affecting world markets, performance in 2023 was dented by the capital-intensive nature of the sector. The HHI fell 3.7%, to 483.8, underperforming the main London markets – FTSE 100 (+3.8%) and FTSE All-Share (3.8%) but outperforming the FTSE AIM All-Share Index (
Companies: TXG ETXPF NDVA TSVT BCOW Z29 TXG NCYT GNS SUN AMS OMG APH EKF EAH IMM AGL DEMG AGY TSTL IPO GDR TRX HVO CTEC OXB DEST VLG IXI VAL INDV AGR AVCT BAI 123F IMCR BCOW
Hardman & Co
TPXimpact reports Q3 is in line with expectations and maintains FY24 and FY25 guidance.
Companies: TPXimpact Holdings PLC
Dowgate Capital
Companies: Windward Ltd.
Canaccord Genuity
Share: